TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 2, 1998, Pages 383-388

  Uckun, Fatih M ^a,b   Chelstrom, Lisa M ^b   Tuel Ahlgren, Lisa ^b   Dibirdik, Ilker ^b   Irvin, James D ^c   Langlie, Mridula Chandan ^d   Myers, Dorothea E ^d  

^a Department of Genetics   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c Texas State University   (United States)

^d Alexander and Parker Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY B53; POKEWEED ANTIVIRUS PROTEIN; STAVUDINE; TXU ANTI CD7 POKEWEED ANTIVIRUS PROTEIN; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DOSE RESPONSE; DRUG CONJUGATION; DRUG POTENCY; HUMAN IMMUNODEFICIENCY VIRUS; MONKEY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANIMALS; ANTI-HIV AGENTS; DISEASE MODELS, ANIMAL; HIV-1; HUMANS; IMMUNOCONJUGATES; MACACA FASCICULARIS; MICE; MICE, SCID; N-GLYCOSYL HYDROLASES; PLANT PROTEINS; STAVUDINE; ZIDOVUDINE;

EID: 0031943905     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Aron, G. M., and J. D. Irvin. 1980. Inhibition of herpes simplex virus multiplication by the pokeweed antiviral protein. Antimicrob. Agents Chemother. 17:1032.
2. Chen, Z. C., J. F. Antoniw, R. F. White, and Q. Lin. 1992. Effect of pokeweed antiviral protein (PAP) on the infection of plant viruses. Plant Pathol. 40: 612.
3. Endo, Y., K. Tsurugi, and J. M. Lambert. 1988. The site of action of six different ribosome-inactivating proteins from plants on eukaryotic ribosomes: the RNA N-glycosidase activity of the proteins. Biochem. Biophys. Res. Commun. 150:1032-1036.
4. + cells. Antimicrob. Agents Chemother. 37:835.
5. Erice, A., K. J. Sannerud, V. L. Leske, D. Aeppli, and H. H. Balfour. 1992. Sensitive microculture method for isolation of human immunodeficiency virus type 1 from blood leukocytes. J. Clin. Microbiol. 30:444-448.
6. Fauci, A. S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239:617-622.
7. Fauci, A. S., S. M. Schnittman, G. Poli, S. Koenig, and G. Pantaleo. 1991. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann. Intern. Med. 114:678-693.
8. Gehrz, R. C., C. Wilson, J. Eckhardt, D. Myers, J. D. Irvin, and F. M. Uckun. 1991. Treatment of human cytomegalovirus (HCMV) with novel antiviral immunoconjugates, p. 353-356. In M. P. Landin (ed.), Progress in cytomegalovirus research. Elsevier Science Publishers BV, Amsterdam, The Netherlands.
9. Goudsmit, J., J. M. A. Lange, D. A. Paul, and G. J. Dawson. 1987. Antigenemia and antibody titers to core and envelope antigens in AIDS, AIDS-related complex, and subclinical human immunodeficiency virus infection. J. Infect. Dis. 155:558-560.
10. Hartley, M. R., G. Legname, R. Osborn, Z. Chen, and J. M. Lord. 1991. Single-chain ribosome inactivating proteins from plants depurinate Escherichia coli 23S ribosomal RNA. FEBS Lett. 290:65-68.
11. Ho, D. D., R. J. Pomerantz, and J. C. Kaplan. 1987. Pathogenesis of infection with human immunodeficiency virus. N. Engl. J. Med. 317:278-286.
12. Irvin, J. 1983. Pokeweed antiviral protein. Pharmacol. Ther. 21:371-387.
13. Irvin, J. D., and F. M. Uckun. 1992. Pokeweed antiviral protein: ribosome inactivation and therapeutic applications. Pharmacol. Ther. 55:279-302.
14. Jackson, J. B., S. Y. Kwok, J. J. Sninsky, J. S. Hopsicker, K. J. Sannerud, F. S. Rhame, K. Henry, M. Simpson, and H. H. Balfour, Jr. 1990. Human immunodeficiency virus type 1 detected in all seropositive symptomatic and asymptomatic individuals. J. Clin. Microbiol. 28:16-19.
15. Levy, J. A., and J. Shimabukuro. 1985. Recovery of AIDS-associated retroviruses from patients with AIDS or AIDS-related conditions and from clinically healthy individuals. J. Infect. Dis. 152:734-738.
16. Mosier, D. E., R. Y. Gulizia, S. M. Baird, D. B. Wilson, D. H. Spector, and S. A. Spector. 1991. Human immunodeficiency virus infection of human PBL-SCID mice. Science 251:791-794.
17. Myers, D. E., X. Jun, D. Clementson, R. Donelson, A. Sicheneder, N. Hoffman, K., Bell, M. Sarquis, M. Langlie, and F. M. Uckun. 1997. Large scale manufacturing of TXU (anti-CD7)-pokeweed antiviral protein (PAP) immunoconjugate for clinical trials. Leukemia Lymphoma 27:275-302.
18. Ou, C.-Y., S. Kwok, S. W. Mitchell, D. H. Mackm, J. J. Sninsky, J. W. Krebs, P. Feorino, U. Warefield, and G. Schochetman. 1988. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 239:295-297.
19. Teltow, G. J., J. D. Irvin, and G. M. Aron. 1983. Inhibition of herpes simplex virus DNA synthesis by pokeweed antiviral protein. Antimicrob. Agents Chemother. 23:390.
20. Tomlinson, J. A., V. M. Walker, T. H. Flewett, and G. R. Barclay. 1974. The inhibition of infection of cucumber mosaic virus and influenza virus by extracts from Phytolacca americana. J. Gen. Virol. 22:225-232.
21. Ussery, M. A., J. D. Irvin, and B. Hardesty. 1977. Inhibition of poliovirus replication by a plant antiviral peptide. Ann. N. Y. Acad. Sci. 284:431.
22. Waurzyniak, B., E. A. Schneider, N. Tumer, Y. Yanishevski, R. Gunther, L. M. Chelstrom, H. Wendorf, D. E. Myers, J. D. Irvin, Y. Messinger, O. Ek, T. Zeren, M. Chandan-Langlie, W. E. Evans, and F. M. Uckun. 1997. In vivo toxicity, pharmacokinetics, and antileukemic activity of TXU (anti-CD7)-pokeweed antiviral protein immunotoxin. Clin. Cancer Res. 3:881-890.
23. + cells by monoclonal antibodies. Nature 347:92-95.